These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy. Friedman SD; Poliachik SL; Carter GT; Budech CB; Bird TD; Shaw DW Muscle Nerve; 2012 Apr; 45(4):500-6. PubMed ID: 22431082 [TBL] [Abstract][Full Text] [Related]
3. Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy. Dahlqvist JR; Andersen G; Khawajazada T; Vissing C; Thomsen C; Vissing J J Neurol; 2019 May; 266(5):1127-1135. PubMed ID: 30778707 [TBL] [Abstract][Full Text] [Related]
4. Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1. Lareau-Trudel E; Le Troter A; Ghattas B; Pouget J; Attarian S; Bendahan D; Salort-Campana E PLoS One; 2015; 10(7):e0132717. PubMed ID: 26181385 [TBL] [Abstract][Full Text] [Related]
5. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration. Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861 [TBL] [Abstract][Full Text] [Related]
6. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study. Ragozzino E; Bortolani S; Di Pietro L; Papait A; Parolini O; Monforte M; Tasca G; Ricci E Acta Neuropathol Commun; 2023 Oct; 11(1):165. PubMed ID: 37849014 [TBL] [Abstract][Full Text] [Related]
7. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. Tasca G; Pescatori M; Monforte M; Mirabella M; Iannaccone E; Frusciante R; Cubeddu T; Laschena F; Ottaviani P; Ricci E PLoS One; 2012; 7(6):e38779. PubMed ID: 22719944 [TBL] [Abstract][Full Text] [Related]
8. Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging. Monforte M; Laschena F; Ottaviani P; Bagnato MR; Pichiecchio A; Tasca G; Ricci E J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1258-1265. PubMed ID: 31668022 [TBL] [Abstract][Full Text] [Related]
9. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism. Kan HE; Klomp DW; Wohlgemuth M; van Loosbroek-Wagemans I; van Engelen BG; Padberg GW; Heerschap A NMR Biomed; 2010 Jul; 23(6):563-8. PubMed ID: 20175146 [TBL] [Abstract][Full Text] [Related]
10. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315 [TBL] [Abstract][Full Text] [Related]
11. MRI change metrics of facioscapulohumeral muscular dystrophy: Stir and T1. Ferguson MR; Poliachik SL; Budech CB; Gove NE; Carter GT; Wang LH; Miller DG; Shaw DWW; Friedman SD Muscle Nerve; 2018 Jun; 57(6):905-912. PubMed ID: 29236297 [TBL] [Abstract][Full Text] [Related]
12. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy. Janssen BH; Pillen S; Voet NB; Heerschap A; van Engelen BG; van Alfen N Muscle Nerve; 2014 Dec; 50(6):968-75. PubMed ID: 24659533 [TBL] [Abstract][Full Text] [Related]
13. Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy. Leung DG; Carrino JA; Wagner KR; Jacobs MA Muscle Nerve; 2015 Oct; 52(4):512-20. PubMed ID: 25641525 [TBL] [Abstract][Full Text] [Related]